Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 4—April 2013

Novel Serotype of Bluetongue Virus, Western North America

On This Page
Article Metrics
citations of this article
EID Journal Metrics on Scopus

Cite This Article

To the Editor: Bluetongue is an arboviral disease of domestic and wild ruminants characterized by vascular injury that produces widespread edema and tissue necrosis (1). Bluetongue virus (BTV), the causative agent of bluetongue, is the prototype virus of the family Reoviridae and the genus Orbivirus (2).

BTV occurs throughout temperate and tropical areas of the world coincident with the distribution of vector Culicoides spp. midges (35). Different midge species transmit different constellations of BTV serotypes in distinct global episystems (3,5). For example, C. sonorensis is the principal, if not exclusive, vector of BTV serotypes 10, 11, 13, and 17 in much of North America, whereas C. insignis is the major vector of multiple BTV serotypes (including BTV 1–4, 6, 8, 12, 17, 19, 20, and probably others) in the Caribbean basin, Central America, and South America. C. insignis is also found in the southeastern United States, and although this species might have recently expanded its range in the region, its distribution in North America remains poorly defined. Serotypes of BTV other than 10, 11, 13, and 17 are found in areas of the United States: BTV-2 was first reported in Florida in 1982. Since 1998, ten additional serotypes (BTV-1, 3, 5, 6, 9, 12, 14, 19, 22, and 24) have been identified in the southeastern United States (6).

Approximately 26 BTV serotypes have been described and the global distribution of BTV has recently been altered (2,4). Coincident with the invasion of novel BTV serotypes into the southeastern United States (6), likely by extension from the adjacent Caribbean basin, multiple BTV serotypes have spread throughout much of continental Europe and parts of the British Isles and Scandinavia, precipitating an economically devastating epidemic (7). Similarly, ongoing surveillance has identified novel BTV serotypes in regions to which it historically has been endemic (e.g., Australia and the Middle East) (2). Climate change may have contributed to this dramatic recent expansion in global distribution of BTV, most notably in Europe (8).

Bluetongue was first described in the late 19th century among sheep brought from Europe to South Africa, and later in North America in ≈1950 (4). Surveillance in western North America since that time has confirmed that only BTV-10, 11, 13 and 17 are present in this region, including our recent intensive surveillance of sentinel cattle on dairy farms throughout California, USA (9,10).

However, during investigation of an outbreak of acute coronitis and ulcerative stomatitis among cattle at a dairy farm in the northern Sacramento Valley in California in August 2010, a blood sample from a heifer was found by using described methods (10) to be positive for BTV by serogroup-specific quantitative reverse transcription PCR (qRT-PCR) but negative by serotype-specific RT-qPCRs for BTV-10, 11, 13, and 17.


Thumbnail of Cladogram comparing the L2 genes of different bluetongue virus (BTV) serotypes and global strains of BTV serotype 2 (BTV-2) with that of a virus isolated in northern California, USA (2-California-2010; GenBank accession nos. JQ822248–JQ822257). Viruses are identified by serotype, country/region of origin, and for isolates of BTV serotype 2, year of identification. Bootstrap percentages are indicated at selected branching points. EHDV1, epizootic hemorrhagic disease of deer virus ser

Figure. . . Cladogram comparing the L2 genes of different bluetongue virus (BTV) serotypes and global strains of BTV serotype 2 (BTV-2) with that of a virus isolated in northern California, USA...

Further analysis using additional serotype-specific RT-qPCRs identified virus in the blood sample as BTV-2. BTV was isolated in primary bovine endothelial cells from blood collected from the heifer. Sequence analysis of the serotype-specific L2 gene of the virus isolate confirmed it to be BTV-2 (2), and phylogenetic analyses showed it to be most closely related to a strain of BTV-2 isolated in Florida in 1999 (Figure). However, sequence analysis of the entire genome of the virus from California indicated that it is a reassortant that includes genes from BTV-6 and BTV-2. Specifically, genes encoding the viral protein 1 polymerase and viral protein 3 major core protein segregate with those of the US prototype strain of BTV-6 (isolated in 2006), but other genes are derived from BTV-2. BTV-2 and BTV-6 have been isolated only in the southeastern United States, which indicates translocation within the United States of reassortant BTV-2.

How this virus spread to California is not known, and its distribution in the United States is uncertain because there is no comprehensive national BTV surveillance program. However, BTV-2 was not detected previously in California, suggesting that this serotype was recently introduced into the region or that it is uncommon. Identification of this novel BTV serotype in western North America emphasizes the need for ongoing entomologic and livestock surveillance, particularly in light of recent changes in the global distribution and nature of BTV infection (4,6,8).


N. James MaclachlanComments to Author , William C. Wilson, Beate M. Crossley, Christie E. Mayo, Dane C. Jasperson, Richard E. Breitmeyer, and Annette M. Whiteford
Author affiliations: Author affiliations: University of California, Davis, California, USA (N.J. Maclachlan, B.M. Crossley, C.E. Mayo, R.E. Breitmeyer); US Department of Agriculture–Agricultural Research Service, Manhattan, Kansas, USA (W.C. Wilson, D.C. Jasperson); California Department of Food and Agriculture, Sacramento, California, USA (A.M. Whiteford)



  1. Maclachlan  NJ, Drew  CP, Darpel  KE, Worwa  G. The pathology and pathogenesis of bluetongue. J Comp Pathol. 2009;141:116. DOIPubMedGoogle Scholar
  2. Maan  S, Maan  NS, Nomikou  K, Batten  C, Antony  F, Belaganahalli  MN, Novel bluetongue virus serotype from Kuwait. Emerg Infect Dis. 2011;17:8869. DOIPubMedGoogle Scholar
  3. Gibbs  EP, Greiner  EC. The epidemiology of bluetongue. Comp Immunol Microbiol Infect Dis. 1994;17:20720. DOIPubMedGoogle Scholar
  4. Maclachlan  NJ. Bluetongue: History, global epidemiology, and pathogenesis. Prev Vet Med. 2011;102:10711. DOIPubMedGoogle Scholar
  5. Tabachnick  WJ. Culicoides and the global epidemiology of bluetongue virus infection. Vet Ital. 2004;40:14450 .PubMedGoogle Scholar
  6. Johnson  DJ. Identification of new United States bluetongue types. Proceedings of the United States Animal Health Association. 2011;111:20910.
  7. Saegerman  C, Berkvens  D, Mellor  PS. Bluetongue epidemiology in the European Union. Emerg Infect Dis. 2008;14:53944. DOIPubMedGoogle Scholar
  8. Purse  BV, Brown  HE, Harrup  L, Mertens  PP, Rogers  DJ. Invasion of bluetongue and other orbivirus infections into Europe: the role of biological and climatic processes. Rev Sci Tech. 2008;27:42742 .PubMedGoogle Scholar
  9. Osburn  BI, McGowan  B, Heron  B, Loomis  E, Bushnell  R, Stott  JL, Epizootiologic study of bluetongue: virologic and serologic results. Am J Vet Res. 1981;42:8847 .PubMedGoogle Scholar
  10. Mayo  CE, Barker  CM, Mullens  BA, Gerry  AC, Mertens  PP, Maan  S, The combination of abundance and infection rates of Culicoides sonorensis estimates risk of subsequent bluetongue virus infection of sentinel cattle on California dairy farms. Vet Parasitol. 2012;187:295301. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid1904.120347

Related Links


Table of Contents – Volume 19, Number 4—April 2013


Please use the form below to submit correspondence to the authors or contact them at the following address:

N. James Maclachlan, Department of Veterinary Medicine, Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA

Send To

10000 character(s) remaining.


Page created: January 17, 2013
Page updated: January 17, 2013
Page reviewed: January 17, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.